Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management under the brand name Zepbound
In a healthy organism with normal copper excretion this may be well tolerated within some range
Oral supplementation is preferable here, since smaller, oral doses are often better tolerated by the body
This page is intended to provide educational, research-use-only information about 5-Amino-1MQ vial materials, laboratory compound handling, research material quality control, HPLC analysis, LC-MS verification, and related research compound resources
In rare cases, particularly with severe megaloblastic anaemia, rapid correction of B12 deficiency can affect potassium distribution in the body